It sounds more like an old-school radial aircraft engine than anything that should power an automobile of any kind.

The life sciences business is characterized by demands in preclinical discovery and research. Revvity has been able to offer a more complete workflow to customers in this segment, building off the ...

Management expects organic growth of 3%-5% for full-year 2025. This guidance assumes stable demand conditions and no significant improvement in market recovery. Full-year adjusted operating margins ...

The firm reported that its full-year 2024 revenues were up slightly as a rise in the diagnostics business was mostly offset by a decline in life sciences business.